Samuel Mok

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center

Affiliated withThe University of Texas MD Anderson Cancer Center

Research Area

Biography

Samuel Mok has not added Biography.
If you are Samuel Mok and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. Molecular cancer therapeutics\| PubMed ID: 18645009	2008
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc\| PubMed ID: 19525924	2009
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. The American journal of pathology\| PubMed ID: 20802181	2010
Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21278312	2011
The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. The American journal of surgical pathology\| PubMed ID: 21451362	2011
Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia (New York, N.Y.)\| PubMed ID: 21532880	2011
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma. Gynecologic oncology\| PubMed ID: 21726895	2011
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23344261	2013
PAX2 Expression in Ovarian Cancer. International journal of molecular sciences\| PubMed ID: 23502471	2013
Poor survival with wild-type TP53 ovarian cancer? Gynecologic oncology\| PubMed ID: 23800698	2013
TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer research\| PubMed ID: 23824740	2013
FGF18 as a prognostic and therapeutic biomarker in ovarian cancer. The Journal of clinical investigation\| PubMed ID: 24018557	2013
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PloS one\| PubMed ID: 24312594	2013
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. The Journal of pathology\| PubMed ID: 24549645	2013
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. Cancer\| PubMed ID: 25042259	2014
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nature communications\| PubMed ID: 25277212	2014
CAF reprogramming inhibits ovarian cancer progression. Cell cycle (Georgetown, Tex.)\| PubMed ID: 25483059	2014
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. American journal of physiology. Cell physiology\| PubMed ID: 26224579	2015
KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget\| PubMed ID: 26397136	2015
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment. Biomolecules\| PubMed ID: 26751490	2016
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nature communications\| PubMed ID: 27021436	2016
Monitoring of ovarian cancer cell invasion in real time with frequency-dependent impedance measurement. American journal of physiology. Cell physiology\| PubMed ID: 27784677	2016
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Oncotarget\| PubMed ID: 28199976	2017
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. The Journal of pathology\| PubMed ID: 28247413	2017
Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28264871	2017
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI insight\| PubMed ID: 28814667	2017
Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis. Scientific reports\| PubMed ID: 28871211	2017
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance. The Journal of clinical investigation\| PubMed ID: 29251630	2018
Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision. Cancers\| PubMed ID: 29466291	2018
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer. Journal of the National Cancer Institute\| PubMed ID: 29860390	2019
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers\| PubMed ID: 30469497	2018
Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 31332047	2019
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature. Cancer immunology, immunotherapy : CII\| PubMed ID: 31515669	2019
Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers. Nature communications\| PubMed ID: 31554806	2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 31871106	2020
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression. Cancers\| PubMed ID: 31906456	2020
Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer. Cancer science\| PubMed ID: 32058624	2020
Pathogenesis and Clinical Management of Uterine Serous Carcinoma. Cancers\| PubMed ID: 32183290	2020
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment. Nature communications\| PubMed ID: 32669559	2020
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers\| PubMed ID: 32867127	2020
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. 2020, , 2436. Cancers\| PubMed ID: 33557446	2021
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. Journal of the National Cancer Institute\| PubMed ID: 33729494	2021
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers\| PubMed ID: 33917869	2021
Ryanodine receptor 1-mediated Ca signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes. Journal of experimental & clinical cancer research : CR\| PubMed ID: 35953818	2022
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors. Cancer research\| PubMed ID: 36787106	2023
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors. Gynecologic oncology\| PubMed ID: 36905875	2023
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors. Molecular cancer research : MCR\| PubMed ID: 37068116	2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell\| PubMed ID: 37541199	2023
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses. Cancers\| PubMed ID: 38473208	2024
Spatial transcriptome reveals histology-correlated immune signature learnt by deep learning attention mechanism on H&E-stained images for ovarian cancer prognosis. Journal of translational medicine\| PubMed ID: 39856778	2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics. Gynecologic oncology\| PubMed ID: 40279981	2025
Multiplexed imaging mass cytometry reveals tumor-immune microenvironment-dependent hormone receptor expression in adult type ovarian granulosa cell tumors. Cancer research communications\| PubMed ID: 41042551	2025